Office Hours… Nick Mourlas, Johnson & Johnson Innovation, New Ventures

Apr 28 2016

Making connections to the correct resources is one of the goals of the Johnson & Johnson Innovation, JLABS program. In order to facilitate the process, we are continuing our one-on-one meetings with Johnson & Johnson Innovation team members. We are happy to announce that Nick Mourlas, Senior Director New Ventures, will be available on Thursday, April 28th for 1-on-1 meetings with JLABS companies. Nick is looking forward to finding ways to leverage his role at Johnson & Johnson Innovation to help your business succeed. Please sign up for a timeslot below (one per company please).

Start times:
8:30 am
9:15 am
10:00 am
10:45 am
11:30 pm
1:00 pm
1:45 pm
2:15 pm
3:15 pm
4:00 pm

Meeting time is 30 Minutes . Please email by April 21st, a brief, high level pitch deck in order to help Nick prepare for your meeting. Email the deck to Shirley.

Please be prepared to discuss your current progress, short and long term milestones and your thoughts on key areas of cooperation that would be beneficial to your success.

Dubai Conference Room - 3004
329 Oyster Point Blvd - 3rd Floor
South San Francisco, California
Map It

Nick Mourlas | Senior Director of New Ventures, Johnson & Johnson Innovation, California
Nick's role within New Ventures focuses on medical device innovation in support of the general surgery, orthopedics, and cardiology businesses. His charge is to identify licensing, collaboration, and investment opportunities highly aligned with J&J business strategies by building relationships with entrepreneurs, venture investors, and key opinion leaders. Nick and the New Ventures team employ a broad array of deal structures in order to best fit the specific needs of the innovation opportunity, as appropriate collaborating with JJDC (equity investments) and JLABS (incubator).
Previously he served as PARC's Director of Global Healthcare Innovation and as the Xerox Innovation Group's Healthcare Program Manager. His focus was on developing and executing a high-impact innovation strategy that aligned with the long-term roadmap of the Xerox healthcare businesses by identifying and understanding emerging trends in healthcare and technology.
Nick's start-up experience includes founding companies is orthopedics, cardiology, and radiation oncology. He was the CEO of Tarsus Medical - acquired by Integra LifeSciences (IART), and Acumen Medical - acquired by Medtronic (MDT).
Dr. Mourlas holds a Ph.D. in Electrical Engineering from Stanford University where he was the John B. Simpson Biomedical Innovation Technology Fellow in the inaugural year of Stanford's Biodesign Fellowship Program. He also received his AB in Engineering Sciences from Dartmouth College, and a BE from Dartmouth's Thayer School. He regularly guest lectures at Dartmouth College and Stanford on the topic of medical device innovation.
Connect with Nick: Connect on LinkedIn